3[3]Garcia-Tsao G.Gurrent management of the complication of the cirrhosis and portal hypertension.Variceal hemorrhage,ascites and spontaneous bacterial peritonitis[J].Gas-tronenterol,2001,120(4):726-748
4Dong Hua Yang Ming Qing Zhang Jiang Du Chong Xu Oiao Ming Liang Ji Fang Mao Han Rong Qin Zi Rong Fan Department of Gastroenterology,Zhujiang Hospital,the First Military Medical University,Guangzhou 510282,China Laboratory of Molecular Biology,Zhujiang Hospital,the First Military Medical University,Guangzhou,China Departrnent of Biochemistry,the Second Military Medical University,Shanghai,China.Inhibitory effect of IGF-Ⅱ antisense RNA on malignant phenotype of hepatocellular carcinoma[J].World Journal of Gastroenterology,2000,6(2):266-267. 被引量：54
5[5]Ichikawa Ⅰ.Will angiotensin Ⅱ receptor antagonists be renoprotective in human[J].Kidney Int,1996,50(11):684-691
1[1]Garcia-Tsao G.Current management of the complication of the cirrhosis and portal hypertension.Variceal hemorrhage,ascites and spontaneous bacterial peritonitis.Gastroenterol,2001,120(4):726-748
2[2]Kamath PS,Tyce GM,Miller VM,et al.Endothelin-1 modulate intrahepatic resistance in a rat model of noncirrhotic portal hypertension.Hepatology,1999,30(3):401-407
3[3]Rockey D.The cellular pathogenesis of portal hypertension.Stellate cell contractility.Endothelin and nitric oxide.Hepatology,1997,25(1):2-5
4[4]Chan CC,Wang SS,Lee FY,et al.Endothelin-1 induces vasoconstriction on portal-systemic collaterals of portal hypertensive rats.Hepatology,2001,33(5):816-820
5[5]Arroyo V,Guevara M,Gines P.Hepatorenal syndrome in cirrhosis:Pathogenesis and treatment.Gastroenterology,2002,122(8):1658-1676
6[6]Rouyon BA,Montano AA,Akriviadis EA,et al.The serum ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites.Ann Intern Med,1992,117(2):215-220
7[7]Rocky DC,Chang JJ.Reduced nitric oxide production by endothelial cells in cirrhotic rat liver endothelial dysfunction in portal hypertension.Gastroenterology,1998,114(2):344-351
8[8]Wong F,Liu P,Blendis L.The mechanism of improved sodium hemeostatis of low-dose losartan in preascitic cirrhosis.Hepatology,2002,45(6):1449-1458
9[9]Martin PV,Gines P,Schrier RW.Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.N Engl J Med,1998,339(1):533-541
10[10]Villa GL,Barletta G,Pantalio P,et al.Hemodynamic,renal,and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.Hepatology,2001,34(1):19-27
